Selectively inhibit the membrane enzyme H+/K+ ATPase in gastric parietal cells. In clinical trials, lansoprazole is more effective than placebo or histamine (H2)-receptor antagonists in the treatment of reflux oesophagitis.
| Cas No : | 103577-45-3 |
|---|---|
| Name : | Lansoprazole |
| Synonyms : | (RS)-2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole |
| Molecular Formula : | C16H14F3N3O2S |
| Melting Point : | 166 °C |
| Boiling Point : | 555.8±60.0 °C |
| Molecular Weight : | 369.363 g/mol |
| Density : | 1.5±0.1 g/cm3 |
| Solubility : | Freely soluble in dimethylformamide; soluble in ethyl acetate, dichloromethane and acetonitrile; very slightly soluble in ether, and practically insoluble in hexane and water. |
Advancing global health through high-quality APIs, intermediates, and surgical products. Trusted solutions driven by innovation, quality, and care.
Copyright © 2025 Healnith Pharmaceuticals All rights reserved.